Pfizer is planning to seek approval for a third dose of its COVID-19 vaccine for distribution.
The never-ending vaccines are here for a disease that is less lethal for those under 30-years-old than the seasonal flu.
Pfizer is ready to seek U.S. authorization for a third dose of its coronavirus vaccine, outlining Thursday a top up shot within 12 months could dramatically boost immunity and counter any virus mutant.
Pfizer’s Dr. Mikael Dolsten told the Associated Press early data from the company’s booster study suggests people’s antibody levels rise five- to 10-fold after a third dose, compared to their second dose months earlier.
In April, Pfizer flagged plans to ask the Food and Drug Administration (FDA) for emergency authorization of a third dose, as Breitbart News reported.
“We believe that the third dose will raise the antibody response 10- to 20- fold,” Pfizer CEO Albert Bourla said at the time, likening it to the annual flu